tiprankstipranks
Advertisement
Advertisement
GYRE Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsGYRE Upcoming Earnings Report: What to Expect?
1M ago
Gyre Therapeutics Completes Cullgen Acquisition and Leadership Transition
Premium
Company Announcements
Gyre Therapeutics Completes Cullgen Acquisition and Leadership Transition
1M ago
Gyre Therapeutics Files NDA in China for F351
Premium
Company Announcements
Gyre Therapeutics Files NDA in China for F351
3M ago
Gyre Therapeutics reports Q4 EPS (2c), consensus 1c
PremiumThe FlyGyre Therapeutics reports Q4 EPS (2c), consensus 1c
3M ago
Gyre Therapeutics sees FY26 revenue $100.5M-$111M, consensus $148M
Premium
The Fly
Gyre Therapeutics sees FY26 revenue $100.5M-$111M, consensus $148M
3M ago
Gyre Therapeutics to Acquire Cullgen in All-Stock Merger
Premium
Company Announcements
Gyre Therapeutics to Acquire Cullgen in All-Stock Merger
3M ago
Gyre Therapeutics Advances Hydronidone Toward China Approval
PremiumCompany AnnouncementsGyre Therapeutics Advances Hydronidone Toward China Approval
5M ago
Gyre Therapeutics announces alignment with China’s CDE on hydronidone
Premium
The Fly
Gyre Therapeutics announces alignment with China’s CDE on hydronidone
5M ago
Gyre Therapeutics Reports Strong Q3 2025 Results
Premium
Company Announcements
Gyre Therapeutics Reports Strong Q3 2025 Results
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100